Back
Genetic Technologies Vs. Kazia Therapeutics Industry Stock Comparison
Sell
36
GENE
Genetic Technologies
Last Price:
2.24
Seasonality Move:
1.86%
Sell
24
KZIA
Kazia Therapeutics
Last Price:
0.28
Seasonality Move:
-16.01%
Sell
36
Genetic Technologies (GENE)
is a Sell
Is Genetic Technologies a Buy, Sell or Hold?
- The current Genetic Technologies [GENE] share price is $2.22. The Score for GENE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- GENE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Kazia Therapeutics (KZIA)
is a Sell
Is Kazia Therapeutics a Buy, Sell or Hold?
- The current Kazia Therapeutics [KZIA] share price is $0.28. The Score for KZIA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- KZIA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GENE Stock Price Chart
What is Genetic Technologies's stock price today?
-
The Genetic Technologies share price today is $2.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GENE is experiencing selling pressure, which indicates risk of future bearish movement.
KZIA Stock Price Chart
What is Kazia Therapeutics's stock price today?
-
The Kazia Therapeutics share price today is $0.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KZIA is experiencing slight selling pressure.
GENE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 37.76 | Sell |
| Chaikin Money Flow: | -18194 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.31 - 3.05) | Sell |
| Bollinger Bands (100): | (2.05 - 2.81) | Sell |
KZIA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 39.52 | Sell |
| Chaikin Money Flow: | -154128 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.31 - 0.39) | Sell |
| Bollinger Bands (100): | (0.26 - 0.4) | Sell |
GENE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.28 | Sell |
| 20-day SMA: | 2.64 | Sell |
| 50-day SMA: | 2.58 | Sell |
| 200-day SMA: | 3.1 | Sell |
| 8-day EMA: | 2.34 | Sell |
| 20-day EMA: | 2.5 | Sell |
| 50-day EMA: | 2.56 | Sell |
| 200-day EMA: | 3.19 | Sell |
KZIA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.35 | Sell |
| 20-day SMA: | 0.36 | Sell |
| 50-day SMA: | 0.3 | Sell |
| 200-day SMA: | 0.58 | Sell |
| 8-day EMA: | 0.33 | Sell |
| 20-day EMA: | 0.34 | Sell |
| 50-day EMA: | 0.33 | Sell |
| 200-day EMA: | 0.6 | Sell |
Genetic Technologies Earnings Growth & GENE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kazia Therapeutics Earnings Growth & KZIA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.01 per share.
Genetic Technologies Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kazia Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||